Card image cap
Positive effects of EMPs in alleviating lung inflammation

Endothelial microparticles from primary pulmonary microvascular endothelial cells have been found mediating lung inflammation in COPD. According to a study by a team of researchers from the Department of Respiratory and Critical Care Medicine at The Second Xiangya Hospital of Central South University, China, EMPs do so by transferring miR-126 and thus magnify the anti-inflammatory effect of EMPs, which may provide a novel therapeutic alternative for COPD. The team said that both the in vitro and in vivo studies demonstrated that mRNA and protein levels of inflammation-related factors were significantly increased in the COPD group, while EMPs could dramatically reverse these increases. The study also found that overexpression of miR-126 in EMPs inhibits HMGB1 expression and further magnifies anti-inflammatory effects of EMPs.



Content by Future Medicine

Disclaimer :
The author(s)' thoughts and opinions in this article are their own and do not necessarily reflect DocMode's viewpoint. The article is in no way created or edited by DocMode.

Supported by Koye Pharmaceuticals

Submit a Comment